AAAAAA
Results:
1-17
|
Results: 17
Authors:
Fournier, A
Barsoum, J
Fickl, R
Oprisiu, R
El Esper, N
Moriniere, P
Citation: A. Fournier et al., Sevelamer, Ca x P product and vitamin D, NEPH DIAL T, 16(2), 2001, pp. 429-429
Authors:
Fournier, A
Oprisiu, R
Mazouz, H
Moriniere, P
El Esper, N
Choukroun, G
Citation: A. Fournier et al., Low parathyroid hormone levels and higher risk of hip fractures and mortality, AM J KIDNEY, 38(1), 2001, pp. 222-223
Authors:
Fournier, A
Pruna, A
El Esper, N
Makdassi, R
Oprisiu, R
Westeel, PF
Mazouz, H
Achard, JM
Citation: A. Fournier et al., Captopril prevention project - what shall we do about captopril and the risk of stroke?, NEPH DIAL T, 15(1), 2000, pp. 2-5
Authors:
Bataille, P
Pruna, A
Cardon, G
Bouzernidj, M
El Esper, N
Ghazali, A
Westeel, PF
Achard, JM
Fournier, A
Citation: P. Bataille et al., Renal and hypertensive complications of extracorporeal shock wave lithotripsy (ESWL): which patients are at risk?, PRESSE MED, 29(1), 2000, pp. 34-38
Authors:
Fournier, A
Oprisiu, R
Albu, AT
Dungaciu, M
El Esper, N
Moriniere, P
Citation: A. Fournier et al., Untitled, AM J KIDNEY, 35(6), 2000, pp. 1248-1249
Authors:
Ghitu, S
Oprisiu, R
Benamar, L
Said, S
Albu, AT
Arsenescu, I
El Esper, N
Moriniere, P
Fournier, A
Citation: S. Ghitu et al., Renal osteodystrophy: Its management in patients on maintenance dialysis, NEPHROLOGIE, 21(8), 2000, pp. 413-424
Authors:
Mazouz, H
Kacso, I
Oprisiu, R
El Esper, N
Makdassi, R
Pruna, A
Fournier, A
Citation: H. Mazouz et al., Factors in the progression of kidney failure excluding dyslipidemia, NEPHROLOGIE, 21(7), 2000, pp. 343-344
Authors:
Hottelart, C
Bako, G
Oprisiu, R
Georgita, A
Presne, C
Sarraj, A
Moriniere, P
El Esper, N
Fournier, A
Citation: C. Hottelart et al., Renal osteodystrophy (2): its treatment before dialysis., NEPHROLOGIE, 21(6), 2000, pp. 275-282
Authors:
Oprisiu, R
Hottelart, C
Ghitsu, S
Said, S
Westeel, PF
Moriniere, P
El Esper, N
Pruna, A
Fournier, A
Citation: R. Oprisiu et al., Renal osteodystrophy: invasive versus non invasive diagnosis of its pathological varieties, NEPHROLOGIE, 21(5), 2000, pp. 229-237
Authors:
Fournier, A
Fardellone, P
Achard, JM
Ghazali, A
Pruna, A
El Esper, N
Moriniere, P
Citation: A. Fournier et al., Importance of vitamin D repletion in uraemia, NEPH DIAL T, 14(4), 1999, pp. 819-823
Authors:
Mazouz, H
Kacso, I
Ghazali, A
El Esper, N
Moriniere, P
Makdassi, R
Hardy, P
Westeel, PF
Achard, JM
Pruna, A
Fournier, A
Citation: H. Mazouz et al., Risk factors of renal failure progression two years prior to dialysisis, CLIN NEPHR, 51(6), 1999, pp. 355-366
Authors:
Fournier, A
Oprisiu, R
Ghitu, S
Said, S
Ghazali, A
Moriniere, P
El Esper, N
Solal, MEC
Brazier, M
Bouillon, R
Pruna, A
Citation: A. Fournier et al., Adynamic bone disease in patients on maintenance dialysis: clinical relevance, non-invasive diagnosis and preventive treatment, NIEREN HOCH, 28(10), 1999, pp. 394-401
Authors:
Kacso, I
Gherman, M
Mazouz, H
Ghazali, A
El Esper, N
Moriniere, P
Makdassi, R
Hardy, P
Westeel, PF
Achard, JM
Pruna, A
Fournier, A
Citation: I. Kacso et al., Progression of renal failure during the two years preceding maintenance dialysis, NEPHROLOGIE, 20(1), 1999, pp. 19-28
Authors:
Hottelart, C
El Esper, N
Achard, JM
Pruna, A
Fournier, A
Citation: C. Hottelart et al., Fenofibrate increases creatininemia but does not alter glomerular filtration rate in patients with mild renal insufficiency, NEPHROLOGIE, 20(1), 1999, pp. 41-44
Authors:
Pruna, A
El Esper, N
Makdassi, R
Oprisiu, R
Fournie, A
Citation: A. Pruna et al., Non-diabetic nephropathies and ACE inhibition, LANCET, 354(9193), 1999, pp. 1905-1906
Authors:
Fournier, A
El Esper, N
Pruna, A
Achard, JM
Citation: A. Fournier et al., Calcium antagonists and renal disease, KIDNEY INT, 56(6), 1999, pp. 2311-2311
Authors:
Bataille, P
Cardon, G
Bouzernidj, M
El Esper, N
Pruna, A
Ghazali, A
Westeel, PF
Achard, JM
Fournier, A
Citation: P. Bataille et al., Renal and hypertensive complications of extracorporeal shock wave lithotripsy: Who is at risk?, UROL INTERN, 62(4), 1999, pp. 195-200
Risultati:
1-17
|